Last reviewed · How we verify
NCT03451994: VOCs
Exploratory Study of Volatile Organic Compounds in Alveolar Breath
trial testing Breath test in Nutritional and Metabolic Diseases in 23 participants. Completed in 11 October 2020.
31 December 2013
Quick facts
| Lead sponsor | Mebo Research, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 23 |
| Start date | 1 October 2011 |
| Primary completion | 31 December 2013 |
| Estimated completion | 11 October 2020 |
| Sites | 2 locations across United Kingdom, United States |
Drugs / interventions tested
- Breath test
Conditions studied
- Nutritional and Metabolic Diseases — all drugs for Nutritional and Metabolic Diseases →
Sponsor
Mebo Research, Inc.
Who can join
18 and older, any sex, with Nutritional and Metabolic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this secondary analysis is to identify breath signatures associated with idiopathic malodor conditions.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Propylene Oxide in Exhaled Breath as a Marker for Discriminating TMAU-like Conditions from TMAU
Gabashvili IS. · · 2024 · DOI 10.1101/2024.04.11.24305677
Verify or expand the search:
- PubMed search for NCT03451994
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Breath test
Trials testing the same drug.
- NCT07243262 — Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2) · recruiting
- NCT06285734 — Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals with Abdominal Distention · recruiting
- NCT05844514 — COlorectal BReath Analysis (COBRA2) · recruiting
- NCT06302660 — Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors · active not recruiting
- NCT06022588 — Chronic Mesenteric Ischemia Breath Testing · NA · completed
Other recruiting trials for Nutritional and Metabolic Diseases
Currently open trials in the same condition.
- NCT06482944 — Whole Food for Families: A Pilot RCT of a Dietary Guidelines-Based Intervention to Prevent Type 2 Diabetes · NA · recruiting
- NCT06386471 — Personalized GI Motility Responses to Diet · NA · recruiting
- NCT06127823 — Effect of Intensive Nutrition Training, Education, and Support in Gestational Diabetes - The INTENSE-GDM TRIAL · NA · active not recruiting
- NCT05723913 — Postprandial Glucose Levels, Gut Microbiota and Supplementation With Functional Foods in Adults · NA · recruiting
- NCT05484999 — The Maternal Well-Being Study · NA · active not recruiting
Other Mebo Research, Inc. trials
Trials by the same sponsor.
- NCT04832932 — The COVID-19 Back-to-Normal Study: Analysis of Multiple Outcomes · unknown
- NCT03582826 — Microbial Basis of Systemic Malodor and "People Allergic To Me" Conditions · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03451994 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mebo Research, Inc.
- Last refreshed: 14 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03451994.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing